Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With General Services Administration Bio-Techne Corporation (NASDAQ:TECH) today announced that the General Services Administration (GSA) has awarded an unlimited 10-year reimbursement...

About Bio-Techne Corporation (NASDAQ: TECH )

ExosomeDx a Bio-Techne Brand

Contact: David Clair , Senior Director, Business Development

[email protected]

SOURCE Bio-Techne Corporation